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Background: Rhegmatogenous retinal detachment (RRD) is the most common form of retinal 
detachment and an ophthalmic emergency. Here, we compared outcomes of primary RRD eyes 
operated with conventional scleral buckling (SB) with cryoretinopexy to those operated with 
standard pars plana vitrectomy (PPV).
Methods: This is an institutional, retrospective, register-based, observational, comparative 
study. Based on the surgical procedure, 319 eyes of 319 patients were divided into two groups: 
SB plus cryotherapy (n=50) and PPV (n=269). Changes in intraocular pressure (IOP) and 
best-corrected visual acuity (BCVA) were recorded at 30 days and reoperation rates within 
180 days postoperatively.
Results: Eyes operated with PPV had less reoperations within the first 180 days as compared 
with SB eyes (P=0.001, log-rank test); however, changes in IOP were more prominent 
(mean ± standard deviation: +8.1±8.8 vs. +4.4±7.0 mmHg, respectively; P=0.006). Changes 
in BCVA did not differ between the surgical procedures.
Conclusion: PPV was associated with higher primary anatomic success rates and lower risk 
of reoperation but significant IOP elevation when compared to SB. These factors should be 
case-specifically considered when choosing treatment modality for primary RRD.
Keywords: rhegmatogenous retinal detachment, vitrectomy, scleral buckling
Abbreviations
AL, axial length; ASA, American Society of Anesthesiologists; BCVA, best-corrected 
visual acuity; CF, counting fingers; HM, hand motion; ILM, internal limiting 
membrane; IOL, intraocular lens; IOP, intraocular pressure; logMAR, logarithm of 
minimum angle of resolution; LP, light perception; NLP, no light perception; PPV, 
pars plana vitrectomy; PVR, proliferative vitreoretinopathy; RD, retinal detachment; 
RPE, retinal pigment epithelial; RRD, rhegmatogenous retinal detachment; SB, scleral 
buckling; VA, visual acuity; VH, vitreous hemorrhage.
Introduction
RRD is a potentially sight-threatening vitreoretinal disease and ophthalmic emergency.1 
PVR, first reported in 1934 by Gonin, is the most frequent and severe complication of 
RRD and a major cause of failure of RRD surgery leading to a need of reoperation, 
with an incidence of 4%–34% in prospective studies.2–4
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SB and PPV are the two most commonly used surgical 
techniques for primary repair of uncomplicated RRD, with 
anatomic success rates in the range of 85%–91%.5–7 SB 
was introduced in 1957, and PPV in 1976.8,9 These tech-
niques can also be used combined.10,11 During the last two 
decades, plenty of clinical studies have been published related 
to clinical risk factors, ocular characteristics, and features 
of RRD, as well as methods of reattachment surgery and 
development of instrumentation. Currently, SB is considered 
as a reference technique for phakic primary RRD, and PPV 
as the first choice for primary pseudophakic RRD as well as 
for posterior and giant retinal tears, and for cases with media 
opacities and complex retinal pathology.
Here, we investigated these two main surgical RRD 
techniques, SB and PPV, and compared the early postop-
erative outcomes and probability of reoperations within 
180 days postoperatively.
Materials and methods
study design
This was an institutional, retrospective, register-based, obser-
vational study. Patients were admitted for primary operation 
for management of RRD in the unit of vitreoretinal surgery, 
in a tertiary governmental hospital, Helsinki University 
Hospital, Helsinki, Finland. Our register-based study was 
conducted according to the tenets of the Declaration of 
Helsinki and was approved by the Institutional Review Board 
of Helsinki University Central Hospital and Hjelt Institute, 
Faculty of Medicine, University of Helsinki. Due to the 
retrospective nature of the study, patient written informed 
consent was deemed not required by the Institutional Review 
Board of Helsinki University Hospital.
Patients and surgical approach
In our study, a total of 319 eyes of 319 patients underwent 
primary vitreoretinal surgery for RRD between January 1 and 
December 31 of 2013. Inclusion criteria were, (1) a history 
of primary RRD, (2) having undergone SB or microincision 
transconjuctival PPV as the primary procedure, and (3) avail-
ability for follow-up for at least 180 days postoperatively. 
Exclusion criterion was a history of combined phacovitrec-
tomy or the presence of traumatic RRD (n=21) or juvenile 
RRD (age #18 years). No postoperative endophthalmitis 
was observed in our study. Eyes which have undergone SB 
plus PPV were not included in the analysis.
Basic patient-related and ophthalmic data collected 
included age, gender, body mass index, ASA physical status 
classification, and systemic diseases as well as operation time, 
extent of RD, status of the lens (crystalline/IOL), presence 
of VH, presence of PVR (grade C), AL, IOP (mmHg), and 
BCVA at baseline.
All patients in the SB group underwent conjunctival peri-
tomy, isolation and looping of rectus muscles, external marking 
of holes/breaks via diathermy, treatment of retinal holes/
breaks with cryoretinopexy (ca. −80°C) via indirect ophthal-
moscopy, and suturing of segmental circumferential silicone 
buckles (foam sponge sutured to the sclera) to support retinal 
holes/breaks with or without external drainage of subretinal 
fluid. Anterior chamber paracentesis was performed when 
needed. Intraocular filtered air injection was performed if 
considered necessary. After conjunctival closure, paraocular 
antibiotic (gensumycin) and corticosteroid injections (kena-
log) were performed. During buckling procedure, the eye 
fundus was viewed through the indirect ophthalmoscope.
All patients in the PPV group underwent a standard 
valved transconjunctival (20, 23, or 25 gauge) vitrectomy 
(Constellation Vision System; Alcon Laboratories, Inc., 
Fort Worth, TX, USA) with noncontact viewing system 
(EIBOS; Möller-Wedel, a Haag-Streit Company, Wedel, 
Germany). Surgical technique consisted of core vitrectomy 
(three-dimensional vitrectomy mode) with cutting rate up 
to 5,000 per minute and suction up to 500 mmHg. Perfluo-
rocarbon liquids were used intraoperatively to reattach the 
retina. Chromodissection with a combination of brilliant blue 
and trypan blue (0.15%) (MembraneBlue-dual®; DORC, 
Zuidland, the Netherlands) was performed for epiretinal 
PVR membrane and ILM staining. Dissection techniques 
were used to remove preretinal (PVR) membranes lying 
on the ILM, and ILM peeling was performed if considered 
necessary. Shaving and removal of peripheral vitreous was 
done under nurse assistance or using an extra chandelier 
according to surgeons’ preference. Peripheral vitreous was 
occasionally visualized using triamcinolone acetonide if 
needed. Drainage of the subretinal fluid was achieved through 
a preexisting original retinal break or via a posterior drain-
age retinotomy in eyes with anterior retinal break(s) with or 
without perfluorocarbon assistance. In PPV cases, retinal 
periphery was examined, and the original hole(s)/break(s)/
tear(s) was treated with endolaser photocoagulation. Fluid–air 
exchange was performed and assisted with flute needle suc-
tion. Different intraocular tamponade agents were used in the 
PPV eyes. The choice of tamponade gas, sulfur hexafluoride 
(20%), perfluoroethane (19%), or perfluoropropane (13.6%), 
was individualized based on the location and characteristics 
of RD and expected patient compliance. Silicone oil tam-
ponade was used in eleven eyes. Removal of silicone oil was 
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not counted as revitrectomy. After gas exchange, sclerotomy 
massage was performed to promote self-sealing. If sclero-
tomy leakage was suspected, a suture was placed.
Of the operated 319 patients, 50 (15.7%) eyes underwent 
SB plus cryotherapy, and 269 (84.3%) underwent PPV as 
initial surgical procedure. The operations were performed 
mostly under retrobulbar local anesthesia (302 eyes; 95%), 
and only a minority of the patients received general anes-
thesia (17 eyes; 5%).
Indication and timing of reoperation was checked from 
patient archives up to 180 days postoperatively. Postopera-
tively, operated patients received dexamethasone (1 mg/mL)/
chloramphenicol (2 mg/mL) eye drops four times a day for 
4 weeks.
Va testing and measurement of iOP
BCVA was measured preoperatively, 1 day postoperatively, 
and at 30 days postoperatively on a standard Snellen chart 
at an observation distance of 5 m. No other intermediate-
phase controls were routinely performed. When the largest 
optotype could not be recognized correctly, the classifica-
tion was very low VA on a semiquantitative scale, such as 
CF, HM, LP, or NLP. For statistical purposes, the Snellen 
values were transformed to the equivalent logMAR units. 
The very low VA measurements were converted as follows: 
CF 1.9 logMAR, HM 2.3 logMAR, LP 2.7 logMAR, and 
NLP 3.0 logMAR.12
IOP was measured with Goldmann applanation 
tonometry.
statistical analysis
Data are given as mean ± standard deviation and range 
(min–max) except absolute number and proportion for nomi-
nal scale, and were analyzed with SPSS 15.0 (IBM Corp., 
Armonk, NY, USA) and R 2012 (R Foundation for Statistical 
Computing, Vienna, Austria). For two-group comparisons, 
qualitative data were analyzed by two-factor χ2 test, ordinal 
measurement scale variables by Mann–Whitney U-test, and 
continuous variables by Student’s t-test. Log-rank test was 
used to estimate the hazard functions of the groups at observed 
event time. P#0.05 was considered statistically significant.
Results
Baseline patient-related and ophthalmic 
characteristics of sB and PPV groups
A total of 319 eyes were included in our study: 50 eyes in 
the SB group and 269 eyes in the PPV group. Baseline char-
acteristics of study groups are given in Table 1.
There were discrepancies in some patient and ocular 
baseline characteristics. The age of presentation varied from 
20 to 74 years with a mean age of 54.3 years in the SB group 
as compared with the age of presentation varying from 35 to 
101 years with a mean age of 61.4 years in the PPV group 
(P=0.001, Table 1). The RD patients in the SB group were 
healthier as defined by ASA physical status classification sys-
tem compared with RD patients in the PPV group (P=0.002). 
Noteworthy, the gender distribution differed among the 
two main study groups, with more males being operated by 
SB than by PPV (P=0.009). Of note, there were altogether 
120 male patients and 199 female patients included in our 
study. There was no difference in the presence of systemic 
diseases such as hypertonia, diabetes mellitus, or coronary 
artery disease among the study groups.
The operation time was significantly shorter in the SB 
than in the PPV group (P=0.005, Table 1). As regards the 
Table 1 Baseline variables
SB (n=50) PPV (n=269) P-value
Patient characteristics
age (years) 54.3±12.2  
(20–74)
61.4±9.9  
(35–101)
0.001
gender, male:female (n; %) 27:23  
(54; 46%)
93:176  
(35; 65%)
0.009
BMi (kg/m2) 26.6±5.4 
(19.7–46.1)
27.0±4.5  
(17.7–45.0)
0.666
ASA classification (1–4) 1.7±0.8 (1–3) 2.1±0.8 (1–4) 0.002
hypertonia 15 (30%) 111 (41%) 0.135
Diabetes mellitus 5 (10%) 34 (13%) 0.601
Coronary artery disease 0 (0%) 29 (11%) 0.149
Ophthalmic characteristics
Operation time (minutes) 67.7±21.3 
(32–133)
77.9±29.6  
(21–235)
0.005
extent of retinal 
detachment in 
1–4 quadrants
30:19:1:0 81:136:44:8 0.001
Pseudophakia (iOl) 1 (2%) 126 (47%) ,0.001
Vitreous hemorrhage 3 (6%) 78 (29%) 0.001
PVr 2 (4%) 30 (11%) 0.122
axial length (mm) 25.3±1.7 
(22.9–30.8)
25.2±1.7  
(22.2–33.1)
0.694
intraocular pressure 
(mmhg)
14.6±4.2  
(1–23)
13.4±4.3 
(1–31)
0.042
BCVa (logMar) 0.41±0.61  
(hM 0.08)
0.64±0.82  
(nlP 0.18)
0.039
Notes: Data are given as mean ± sD and range (min–max) or absolute number and 
proportion. For two-group comparisons, qualitative data were analyzed by two-
factor χ2 test, ordinal measurement data by Mann–Whitney U-test, and continuous 
variables by student’s t-test. P#0.05 was considered statistically significant.
Abbreviations: asa, american society of anesthesiologists; BCVa, best-
corrected visual acuity; BMi, body mass index; hM, hand motion; iOl, intraocular 
lens; logMar, logarithm of minimum angle of resolution; nlP, no light perception; 
PPV, pars plana vitrectomy; PVr, proliferative vitreoretinopathy; sB, scleral buckling; 
sD, standard deviation.
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extent of RRD (the total area of detached quadrants), there 
were statistical differences between the SB and PPV groups 
(P=0.001). While 19.3% of patients in the PPV group had 
a detachment larger than two quadrants, only 2% in the SB 
group presented with this. More accurately, 30 out of 50 eyes 
(60%) operated with SB had retinal detachment less than 
one quadrant (3 clock hours), 19 eyes (38%) had less than 
two quadrants, and in only one eye (2%), three quadrants 
were detached. No patient in the SB group had a total RRD 
(four quadrants). On the contrary, only 81 eyes out of 269 
(30%) operated with PPV had retinal detachment less than 
one quadrant, 136 eyes (51%) had less than two quadrants, 
and 44 eyes (16%) had less than three quadrants. Eight eyes 
(3%) had a total RRD. All in all, more complicated RRD 
cases were operated in our PPV group.
Preoperatively, IOP was lower (P=0.042), and occur-
rence of VH was more common (P=0.001) in eyes oper-
ated with PPV than by SB (Table 1). No difference was 
observed regarding the presence of PVR, or the AL of the 
study eyes between the study groups. Pseudophakic RRD 
eyes (n=127) were all treated with PPV except for one with 
SB (P,0.001).
Outcomes in sB and PPV groups
At 30 days postoperatively, IOP was higher in RRD eyes 
operated with PPV compared to SB (P=0.034, Table 2), with 
the concomitant IOP pressure change after surgery being 
higher in the PPV group (P=0.006, Table 3). The IOP change 
was related to type of endotamponade (Table 4). Also, BCVA 
remained worse in RRD eyes operated with PPV compared 
to SB (P=0.013). However, the BCVA gain was comparable 
between the groups (P= nonsignificant).
reason for reoperation was retinal redetachment
Noteworthy, primary anatomical surgical success rate dif-
fered between the study groups (Kaplan–Meier analysis). 
We found that the eyes operated with primary SB were 
reoperated more commonly within the first 180 postoperative 
days compared with the RRD eyes that underwent primary 
PPV (P=0.001, Figure 1). No gender or age predilection for 
reoperations was noticed between SB or PPV groups (data 
not shown).
Discussion
In our study, primary RRD eyes operated with three-port 
PPV had less reoperations due to retinal redetachment within 
180 days postoperatively as compared with conventional SB 
procedure. The first 6 weeks postoperatively are considered 
as the most important period during which most complica-
tions occur, while most of the retinal redetachments seem 
to occur within six months.13 Only one-sixth of our study 
eyes were treated with SB, demonstrating per se the cur-
rent tendency of vitreoretinal surgeons to treat RRDs with 
PPV.14 The fact that primary SB procedures more often had 
a need for reoperation is of importance. Noteworthy, previ-
ous reports have confirmed that single SB and PPV proce-
dures have similar anatomical and functional outcomes in 
uncomplicated RRD cases.2,5,6,15 Interestingly, more female 
than male patients underwent primary RRD surgery in our 
study hospital, but the reason for this gender discrepancy 
was not clear.
The reasons for inferiority of SB procedure in our 
study could be related to various patient-, eye-, and/or 
surgical technique-related characteristics. Preoperative 
risk factors contributing to RRD reoperation are related to 
Table 2 Postoperative variables
SB (n=50) PPV (n=269) P-value
intraocular 
pressure (mmhg)
18.9±6.3 (9–46) 21.8±8.4 (5–55) 0.034
BCVa (logMar) 0.32±0.39 (hM 0.08) 0.50±0.51 (lP 0.08) 0.013
Notes: Data are given as mean ± sD and range (min–max). For two-group 
comparisons, continuous variables were analyzed by student’s t-test. P#0.05 was 
considered statistically significant. 
Abbreviations: BCVa, best-corrected visual acuity; hM, hand motion; lP, light 
perception; logMar, logarithm of minimum angle of resolution; PPV, pars plana 
vitrectomy; sB, scleral buckling; sD, standard deviation.
Table 3 Postoperative outcome
SB (n=50) PPV (n=269) P-value
intraocular pressure 
change (mmhg)
+4.4±7.0 +8.1±8.8 0.006
BCVa change (logMar) −0.11±0.56 −0.17±0.87 0.642
Notes: Data are given as mean ± sD. For two-group comparisons, continuous 
variables were analyzed by student’s t-test. P#0.05 was considered statistically 
significant.
Abbreviations: BCVa, best-corrected visual acuity; logMar, logarithm of 
minimum angle of resolution; PPV, pars plana vitrectomy; sB, scleral buckling; 
sD, standard deviation.
Table 4 intraocular pressure change (mmhg) according to 
endotamponade
IOP change
no endotamponade (n=2) +2.5±10.6
sF6 (n=18) +1.8±6.0
C2F6 (n=144) +7.7±9.0
C3F8 (n=76) +10.1±9.1
silicone oil (n=11) +11.5±10.7
Note: Data are given as mean ± sD.
Abbreviations: IOP, intraocular pressure; SF6, sulfur hexafluoride; C2F6, 
perfluoroethane; C3F8, perfluoropropane; SD, standard deviation.
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longer duration of retinal detachment, presence of PVR, 
extent of RD, presence of VH, structure of the eyeball 
(longer AL, myopia), systemic diseases, and medication of 
the patient.16 Generally, PVR formation is considered more 
pronounced in younger patients2 which, however, was not 
confirmed in our study population. In patients with RRD of 
more than 1-week duration, tissue remodeling phases such 
as mesenchymal transformation of RPE cells toward fibro-
blast- or macrophage-like cell morphology are activated, and 
the risk for PVR is therefore considered higher.3,17 Preopera-
tively, a minority of our primary RRD eyes were diagnosed 
with characteristics of advanced PVR formation (star folds 
or epiretinal membranes) by biomicroscopy, which was 
4% in the SB group compared with 11% in the PPV group, 
paralleling previous studies.18 Since rate of preexisting PVR 
did not significantly differ between our SB and PPV study 
groups, preoperatively observed PVR per se should therefore 
not be related to the increased reoperation rate observed in 
our SB group.
Also, intravitreal hemorrhage has been considered as a 
high-risk factor related to reoperation rate.19 In our study, 
VH was diagnosed significantly more often in eyes operated 
with PPV than in SB eyes, which would not explain the fact 
that prognosis as regards the reoperation rate was worse in 
SB eyes as compared to PPV eyes. Therefore, VH does not 
seem to affect the reoperation rate in our study. Neither is the 
reoperation rate directly associated with involved detached 
retinal quadrants. Interestingly, in our study, pseudophakic 
RRD eyes operated with PPV had more extensive detach-
ments to start with (ie, total area of involved retinal quadrants 
was larger), but these eyes had better postoperative outcome 
and were reoperated less often than SB eyes. Previously, it 
has been postulated that the intact lens provides a physical 
barrier for transmission of inflammatory cytokines from the 
anterior chamber to the vitreous cavity reducing thus the risk 
of redetachment.20 Neither can the reoperations be related 
to duration of surgical procedure, as the eyes operated with 
PPV in our study had longer duration of surgery but better 
postoperative prognosis.
Based on our study results, we think that cryotherapy 
used in SB eyes could cause more changes in retinal tissue 
microarchitecture than laser in PPV eyes. Cryotherapy could 
increase local vitreous-related biochemical factors such 
as various growth factors, extracellular matrix proteolytic 
factors, and other factors contributing thus to breakdown 
of blood–retinal barrier and PVR development in eyes.21,22 
During microincisional valved PPV procedure, more 
complex removal of PVR-causing RPE cells and clumps as 
well as removal of the irregular and rolled edges of the retinal 
break(s) can be accomplished. More complete removal of 
these PVR-causing cells (RPE cells, glial cells, fibroblasts, 
myofibroblasts, erythrocytes), the cytokines (interleukin-1, 
interleukin-6, interleukin-8, interleukin-10, interferon 
gamma, angiopoietin-2, transforming growth factor-β1), 
and matrix metalloproteinases 2 and 9 diminishes PVR 
process17,22,23 and decreases the reoperation rate in vitrecto-
mized eyes compared with SB-operated eyes.
Additional use of cryotherapy per se could also be related 
to higher risk of reoperations in SB eyes24–26 by inducing more 
inflammation and contraction in the SB-treated eyes than 
endolaser treatment in the PPV eyes. Moreover, loss of vitre-
ous during external drainage of subretinal fluid and incarcera-
tion of vitreous to the external drainage sclerotomy can cause 
additional traction and lead to secondary hole/break forma-
tion in SB eyes. Perioperatively undetected retinal holes may 
also play a role in higher redetachment rate in SB-operated 
eyes. Detection of holes might, however, be improved if extra 
chandelier light is used during the SB procedure.27 Lower 
reoperation rate in PPV eyes can also be associated with 
transconjunctival vitrectomies that are known to reduce the 
surgical trauma and postoperative inflammation.28,29
The major limitation of our study was its retrospective and 
register-based design with limited postoperative follow-up. 
Therefore, intraoperative complications arising from surgery 
(such as type and number of iatrogenic breaks, subretinal hem-
orrhage, passage of liquid perfluorocarbon to the subretinal 
space, perforation of sclera/choroid) were not available for 
analysis. Another major limitation was that the operations 
Figure 1 180-Day anatomic success rates of the study eyes.
Notes: hazard of revitrectomy within 180 postoperative days was analyzed by 
log-rank test and compared between the eyes primarily operated with scleral 
buckling (blue; n=50) and pars plana vitrectomy (green; n=269). success rate without 
reoperation within 180 days was 78.0% for scleral buckling and 91.8% for pars plana 
vitrectomy. P=0.001.
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were not done by the same vitreoretinal surgeon. Notably, 
our department is the highest-volume ophthalmic vitreoretinal 
department in Finland, and all the acute-onset emergency 
patients with RRD in the whole of Finland during the week-
ends can be operated in our hospital. Therefore, we consider 
that the criteria for choosing the type of SB or PPV operation 
were generally well established among experienced VR sur-
geons and in compliance with the recommended guidelines,2 
diminishing the surgeon-related confounding effects. In our 
center, we prefer to perform the SB surgery for young, phakic 
patients with attached hyaloid, clear media, and proper iden-
tification of retinal hole(s)/break(s) and/or tears. However, 
when the RRD case is more complicated (pseudophakic RRD, 
VH, multiple breaks, posterior and/or large breaks), we tend 
to perform primary PPV. Another limitation of our study is 
the heterogeneous nature of the study population with no age- 
or gender-matching between our study groups that cannot be 
overcome in real-world clinical studies.
During our study, the economic aspects did not affect the 
decision-making of the surgical process. The VR surgeons 
were able to choose whatever instrumentation was consid-
ered the best choice for the individual patient. Therefore, our 
results might not be generalized to other kinds of health care 
systems around the world, where the patient might pay for 
the treatment by himself/herself or where hospital-related 
resources are more limited.
The strength of our study is that we analyzed all consecu-
tive primary RRD eyes operated in our tertiary institution 
within 1 year. Our RRD study eyes represented mostly 
cases with acute onset, with inflammation and cell prolifera-
tion phases being activated in less than 1-week duration.30 
Including more complicated RRD eyes with longer duration 
might surely have affected our study results. In addition 
to improved surgical technology, improving postsurgical 
prognosis of RRD eyes also demands deeper understand-
ing of the biochemical signaling mechanisms associated 
with intraocular fibrosis-related tissue repair mechanisms.31 
In the future, search for potential biomarkers, that is, dif-
ferentially expressed proteins linked to RRD inflammatory 
pathways, might provide us with knowledge that might 
help in monitoring and predicting the development of the 
RRD in eyes with or without preoperative PVR disease.28,29 
Prospective randomized studies are needed to answer these 
open questions more accurately.
Conclusion
RRD eyes operated with primary PPV had higher anatomic 
success rates within 180 days as compared with SB eyes, 
despite the fact that PPV eyes had more complicated RRD 
to start with (VH, extent of RD, IOL) as compared with less 
complicated RRD in SB eyes. In our study, the patients in 
the SB group were younger, healthier, had smaller RRD area, 
less often had intravitreal hemorrhage, and had better initial 
preoperative BCVA. Despite these facts, they experienced 
more retinal redetachments postoperatively. Benefits and 
disadvantages between SB and PPV treatment modalities 
should be case-specifically considered in primary RRD.
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